Update οn the diagnosis and management of systemic lupus erythematosus

A Fanouriakis, N Tziolos, G Bertsias… - Annals of the rheumatic …, 2021 - ard.bmj.com
Clinical heterogeneity, unpredictable course and flares are characteristics of systemic lupus
erythematosus (SLE). Although SLE is—by and large—a systemic disease, occasionally it …

Cardiovascular disease risk in antiphospholipid syndrome: Thrombo-inflammation and atherothrombosis

MG Tektonidou - Journal of Autoimmunity, 2022 - Elsevier
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the presence
of antiphospholipid antibodies (aPL)(lupus anticoagulant, anticardiolipin antibodies and anti …

High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus

V Oke, I Gunnarsson, J Dorschner, S Eketjäll… - Arthritis research & …, 2019 - Springer
Abstract Background and aim Interferons (IFNs) are considered to be key molecules in the
pathogenesis of systemic lupus erythematosus (SLE). We measured levels of type I, II and III …

Smoke and autoimmunity: The fire behind the disease

C Perricone, M Versini, D Ben-Ami, S Gertel… - Autoimmunity …, 2016 - Elsevier
The association between smoke habit and autoimmunity has been hypothesized a long time
ago. Smoke has been found to play a pathogenic role in certain autoimmune disease as it …

[HTML][HTML] The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus

O Ünlü, S Zuily, D Erkan - European journal of rheumatology, 2016 - ncbi.nlm.nih.gov
Antiphospholipid syndrome (APS) is the association of thrombosis and/or pregnancy
morbidity with antiphospholipid antibodies (aPL). Thirty to forty percent of systemic lupus …

Smoking and the pathophysiology of peripheral artery disease

W Wang, T Zhao, K Geng, G Yuan, Y Chen… - Frontiers in …, 2021 - frontiersin.org
Smoking is one of the most important preventable factors causing peripheral artery disease
(PAD). The purpose of this review is to comprehensively analyze and summarize the …

Life factors acting on systemic lupus erythematosus

J Chen, S Liao, W Pang, F Guo, L Yang, H Liu… - Frontiers in …, 2022 - frontiersin.org
Systemic lupus erythematosus (SLE) is a highly heterogeneous autoimmune disease that
primarily affects women. Currently, in the search for the mechanisms of SLE pathogenesis …

Stroke in systemic lupus erythematosus: a Swedish population-based cohort study

EV Arkema, E Svenungsson, M Von Euler… - Annals of the …, 2017 - ard.bmj.com
Objective To study the occurrence of ischaemic and haemorrhagic stroke in systemic lupus
erythematosus (SLE) compared with the general population by age, sex and time since SLE …

Cardiovascular events in systemic lupus erythematosus: a nationwide study in Spain from the RELESSER registry

A Fernandez-Nebro, Í Rúa-Figueroa, FJ Lopez-Longo… - Medicine, 2015 - journals.lww.com
Cardiovascular Events in Systemic Lupus Erythematosus: A Nat... : Medicine Cardiovascular
Events in Systemic Lupus Erythematosus: A Nationwide Study in Spain From the RELESSER …

The autoimmune ecology

JM Anaya, C Ramirez-Santana, MA Alzate… - Frontiers in …, 2016 - frontiersin.org
Autoimmune diseases (ADs) represent a heterogeneous group of disorders that affect
specific target organs or multiple organ systems. These conditions share common …